InvestorsHub Logo
Followers 91
Posts 11544
Boards Moderated 0
Alias Born 06/06/2014

Re: TempePhil post# 303076

Sunday, 03/14/2021 5:40:22 PM

Sunday, March 14, 2021 5:40:22 PM

Post# of 471331
Your "68%" is mathematically false, but your inference that Donenenab has inferior effect compared to 2-73 for ADCS-ADL is supportable. Though of course you have to take into account that Lily's trial was far larger and more robust.

I would not be surprised to see that 2-73 is in fact superior for that metric in AD. We'll know better in 2022.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News